BE642020A - - Google Patents
Info
- Publication number
- BE642020A BE642020A BE642020A BE642020A BE642020A BE 642020 A BE642020 A BE 642020A BE 642020 A BE642020 A BE 642020A BE 642020 A BE642020 A BE 642020A BE 642020 A BE642020 A BE 642020A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB49140/62A GB1027746A (en) | 1962-12-31 | 1962-12-31 | 17-amino-androstane and -androstene derivatives |
| GB220063 | 1963-01-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE642020A true BE642020A (cg-RX-API-DMAC10.html) | 1964-06-30 |
Family
ID=26237361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE642020A BE642020A (cg-RX-API-DMAC10.html) | 1962-12-31 | 1963-12-31 |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE642020A (cg-RX-API-DMAC10.html) |
| ES (1) | ES294887A1 (cg-RX-API-DMAC10.html) |
| FR (2) | FR1432523A (cg-RX-API-DMAC10.html) |
| GB (1) | GB1027746A (cg-RX-API-DMAC10.html) |
| NL (1) | NL302932A (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU606677B2 (en) * | 1987-04-22 | 1991-02-14 | Merrell Dow Pharmaceuticals Inc. | 17 beta -(cyclopropylimino) androst-5-EN-3 beta- Ol and related compounds useful as C17-20 lyase inhibitors |
| US5075464A (en) * | 1987-04-22 | 1991-12-24 | Merrell Dow Pharmaceuticals Inc. | 17β-(cyclopropylamino)androstene derivatives |
| US4954488A (en) * | 1989-06-14 | 1990-09-04 | Merrell Dow Pharmaceuticals Inc. | Method of treating hyperaldosteronism using 17β-cyclopropylaminoandrostene derivatives |
| US4966898A (en) * | 1989-08-15 | 1990-10-30 | Merrell Dow Pharmaceuticals Inc. | 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors |
-
0
- NL NL302932D patent/NL302932A/xx unknown
-
1962
- 1962-12-31 GB GB49140/62A patent/GB1027746A/en not_active Expired
-
1963
- 1963-12-27 ES ES294887A patent/ES294887A1/es not_active Expired
- 1963-12-30 FR FR958854A patent/FR1432523A/fr not_active Expired
- 1963-12-31 BE BE642020A patent/BE642020A/xx unknown
-
1964
- 1964-01-10 FR FR959970A patent/FR3159M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES294887A1 (es) | 1964-04-16 |
| FR3159M (fr) | 1965-03-01 |
| NL302932A (cg-RX-API-DMAC10.html) | |
| GB1027746A (en) | 1966-04-27 |
| FR1432523A (fr) | 1966-03-25 |